| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,971 |
5,768 |
$339K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,010 |
885 |
$57K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
475 |
436 |
$32K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,813 |
1,552 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,569 |
1,426 |
$17K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
613 |
573 |
$17K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,297 |
2,904 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,411 |
657 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
1,938 |
1,691 |
$3K |
| 87807 |
|
90 |
86 |
$880.79 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,402 |
1,227 |
$560.09 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
396 |
350 |
$439.59 |
| 92551 |
|
34 |
32 |
$249.01 |
| 96160 |
|
44 |
40 |
$90.72 |
| 99173 |
|
60 |
54 |
$50.48 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
12 |
12 |
$14.90 |
| 36416 |
|
1,329 |
1,162 |
$1.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
335 |
288 |
$0.00 |